"Andrew stepped in to lead the medical team at Bayer on a short term contract due to an uplanned absence. He onboarded in record time and was able to effectively lead the team and add real value to the business during the short tenure of the contract. In this time he supported a new launch and ongoing business transformation. Andrew would be an asset to any medical affairs team and I highly recommend him for senior leadership roles in medical affairs" Dr Catherine Donovan, former VP and Head of Medical Affairs, Bayer APAC

ABN 42562510832 Andrew Weekes trading as InspiRx

"Thank you so much for the workshop yesterday. It was excellent, engaging, highly practical, memorable and valuable." Dr Meredith Edwards, ANZ Medical Director, BMS

"Andrew has unique experience to draw upon in the promotional compliance area. He added substantial value coaching my team toward approaches that were both effective and sustainable. He was also instrumental in resolving some complex intercompany challenges without loss of continuity or significant changes in strategy. I would absolutely recommend his expert support in this nuanced area." Dr Alan Watts, former CMD, AbbVie ANZ

"Andrew has a sharp, curious mind and a natural ability to tackle complex problems. He excels at breaking things down into clear, practical frameworks, making even the most challenging issues feel manageable and straightforward. Just as importantly, he’s a strong communicator - able to clearly articulate ideas and engage a room, whether in small discussions or broader forums. Along the way, he consistently offers thoughtful suggestions that add real value." Sophie Seck, Senior Manager Ethics and Compliance, Medicines Australia.

"Andrew's clinical and scientific knowledge, combined with his commercial savvy and contacts in pharma and academia have been greatly valued by Mucpharm. I'd highly recommend a discussion with Andrew if you are looking for a strategic consultant to support your medtech startup, including support with partnering opportunities" Prof. David Morris, co-Founder and CEO, Mucpharm Pty Ltd